Diet and dementia

Journal of the British Menopause Society

Volumn 10, Issue 3, 2004, Pages 113-117

  Whalley, Lawrence J ^a   Starr, John M ^b   Deary, Ian J ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; HOMOCYSTEINE; OMEGA 3 FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADAPTATION; AGING; ALZHEIMER DISEASE; BRAIN FUNCTION; COGNITION; DEMENTIA; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; FEEDING BEHAVIOR; HEALTH STATUS; HUMAN; INCIDENCE; INFLAMMATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POVERTY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANTIOXIDANTS; DEMENTIA; DIET; FEMALE; HUMANS;

EID: 9244262529     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/1362180043654575     Document Type: Review

References (51)

1. Grant WB. Dietary links to Alzheimer's disease: 1999 Update. J Alzheimers Dis 1999; 1: 197-201.
2. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med 1995; 333: 1392-1400.
3. Mayeux R, Costa R, Bell K, et al. Reduced risk of Alzheimer's disease among individuals with low caloric intake. Neurology 1999; 52: A296-297.
4. Hendrie HC, Ogunniyi A, Hall KS, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001; 285: 739-747.
5. Prince JA, Feuk L, Gu HF, et al. Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum Mutat 2003; 22: 363-371.
6. Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia - The Rotterdam Study. Neurology 1999; 53: 1937-1942.
7. Willett WC, Leibel RL. Dietary fat is not a major determinant of body fat. Am J Med 2002; 113: 47-59.
8. Fernyhough LK, Horwath CC, Campbell AJ, et al. Changes in dietary intake during a 6-year follow-up of an older population. Eur J Clin Nutr 1999; 53: 216-225.
9. Simpson ME, Serdula M, Galuska. DA, et al. Walking trends among US adults - The Behavioral Risk Factor Surveillance System, 1987-2000. Am J Prev Med 2003; 25: 95-100.
10. Mack KA, Ahluwalia NB. Monitoring women's health in the United States: Selected chronic disease indicators, 1991-2001 BRFSS. J Women's Health Gender-Based Med 2003; 12: 309-314.
11. Kruman II, Kumaravel TS, Lohani A, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22: 1752-1762.
12. Riggs KM, Spiro A 3rd, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63:306-14.
13. McCaddon A, Davies G, Hudson P, et al. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13: 235-239.
14. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483.
15. Duthie SJ, Whalley LJ, Collins AR, et al. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75: 908-913.
16. McCaddon A, Hudson P, Hill D, et al. Alzheimer's disease and total plasma aminothiols. Biol Psychiatry 2003; 53: 254-260.
17. Whalley LJ, Staff RT, Murray AD, et al. Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people. Neurosci Lett 2003; 341: 173-176.
18. den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126: 170-175.
19. Prins ND, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly - The Rotterdam Scan Study. Neurology 2002; 59: 1375-1380.
20. Clarke R, Grimley Evans J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33: 34-41.
21. Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 2003; 77 1241-1247.
22. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015-2022.
23. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 3223-3229.
24. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
25. Jama JW, Launer LJ, Witteman JC, et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol 1996; 144: 275-280.
26. Mendelsohn AB, Belle SH, Stoehr GP, Ganguli M. Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey. Am J Epidemiol 1998; 148: 38-44.
27. Balluz LS, Kieszak SM, Philen RM, Mulinare J. Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey. Arch Fam Med 2000; 9: 258-262.
28. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54: 1265-1272.
29. Morris MC, Evans DA, Bienias JL, et al. Vitamin E and cognitive decline in older persons. Arch Neurol 2002; 59: 1125-1132.
30. Helmer C, Peuchant E, Letenneur L, et al. Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study. Eur J Clin Nutr 2003; 57: 1555-1561.
31. Grodstein F, Chen J, Willett WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003; 77: 975-984.
32. Gonzalez-Gross M, Marcos A, Pietrzik K. Nutrition and cognitive impairment in the elderly. Br J Nutr 2001; 86: 313-321.
33. Martin A, Youdim K, Szprengiel A, et al. Roles of vitamins E and C on neurodegenerative diseases and cognitive performance. Nutr Rev 2002; 60: 308-326.
34. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996; 312: 608-611.
35. Schmidt R, Hayn M, Reinhart B, et al. Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention Study. J Am Geriatr Soc 1998; 46: 1407-1410.
36. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 2000; 48: 1285-1291.
37. Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging. 2003; 24: 915-919.
38. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997; 336: 1216-1222.
39. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001; 17: 709-712.
40. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992; 340: 1124-1127.
41. Shenkin SD, Whiteman MC, Pattie A, Deary IJ. Supplementation and the elderly: dramatic results? Nutrition 2002; 18: 364; discussion 364-365.
42. Meguid MM, Shenkin A. Introduction: nutritional supplements and the quest to improve human performance-the need for the strictest standards and rigor when reporting clinical trials. Nutrition 2003; 19: 955-956.
43. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment. BMJ 2004; 328: 30-35.
44. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002; 23: 843-853.
45. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 145: 33-41.
46. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 940-946.
47. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000; 35: 1305-1312.
48. Tully AM, Roche HM, Doyle R, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003; 89: 483-489.
49. Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr 2003; 77: 803-808.
50. Whalley LJ, Starr JM, Athawes R, et al. Childhood mental ability and dementia. Neurology 2000; 55: 1455-1459.
51. Brustad M, Braaten T, Lund E. Predictors for cod-liver oil supplement use - the Norwegian Women and Cancer Study. Eur J Clin Nutr 2004; 58: 128-136.